论文部分内容阅读
将 1 93例AL病例分为急性髓性白血病 1 0 8例 (ANL)和急性淋巴细胞性白血病 85例 (ALL)两组 ,把各组患者的初诊髓片进行巨核细胞数量和质量 ,及相应的治疗缓解情况做比较。结果 ,ALL患者以MK减少者多 ,增高者多见于ANL组 ,与ALL组比较差异显著 (P <0 .0 2 5) ;MK增高者缓解率低 ,与MK减少组比较 ,差异显著 (P <0 .0 0 5) ;MK质的异常亦多见于NL组 ,与ALL组比较差异显著 (P <0 .0 0 5) ;MK质的异常缓解率低 (P <0 .0 0 5)。提示MK数量增高、质量异常者预后差。
A total of 1 93 cases of AL were divided into two groups: 108 cases of acute myeloid leukemia (ANL) and 85 cases of acute lymphoblastic leukemia (ALL). The quantity and quality of megakaryocytes in newly diagnosed patients’ The treatment response to be compared. Results, ALL patients with more MK reduction, increased more common in the ANL group, compared with the ALL group significant difference (P <0.05); MK increased remission rate was low, compared with the MK reduction group, the difference was significant <0.001). The abnormality of MK was also found in NL group, which was significantly different from that in ALL group (P <0.05). The abnormal rate of MK remission (P <0.05) . Prompted an increase in the number of MK, poor quality of patients with poor prognosis.